Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024)
Biolife Solutions (BLFS) reported Liabilities from Discontinued Operations of 616000.0 for Q4 2024, down 90.53% year-over-year from 6503000.0 in Q1 2024, and down 90.53% quarter-over-quarter from 6503000.0 in Q4 2023.
Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 616000.0 in Q4 2024.
- Liabilities from Discontinued Operations for Q4 2024 came in at 616000.0, down 90.53% year-over-year; the trailing twelve-month figure through Dec 2024 was 616000.0 (down 90.53% YoY), and the FY2024 annual result was 616000.0, down 90.53% from the prior year.
- Liabilities from Discontinued Operations slipped to 616000.0 in Q4 2024 per BLFS's latest filing, from 6503000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 6503000.0 in Q4 2023 and troughed at 616000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2023 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |